Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oertli Instrumente is a global leader in the development and manufacture of surgical platforms, instruments, and consumables for ophthalmic surgery. Their products are widely used for cataract, glaucoma, and vitreoretinal procedures. The company has set industry benchmarks with innovations such as easyPhaco technology for phacoemulsification and the CataRhex 3 portable surgical system. In June 2024, they received the Swiss Medtech Award recognizing their impact on preventing blindness worldwide[1][2][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oertli Instrumente.